Dr. Reddy's Laboratories Limited
RDY
$12.68
-$0.0211-0.17%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 167.32M | 149.86M | 166.87M | 157.40M | 165.65M |
| Total Depreciation and Amortization | 55.87M | 47.46M | 45.67M | 44.71M | 45.29M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -30.59M | 6.83M | 46.84M | -30.12M | -11.62M |
| Change in Net Operating Assets | -114.22M | -92.93M | -157.53M | -33.26M | -142.42M |
| Cash from Operations | 78.37M | 111.22M | 101.85M | 138.73M | 56.91M |
| Capital Expenditure | -85.19M | -89.97M | -61.26M | -63.15M | -46.08M |
| Sale of Property, Plant, and Equipment | 1.31M | 2.52M | 2.40M | 638.30K | 6.30M |
| Cash Acquisitions | 0.00 | -614.12M | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 19.26M | 473.89M | -183.87M | -74.17M | -154.59M |
| Cash from Investing | -64.62M | -227.68M | -242.73M | -136.68M | -194.38M |
| Total Debt Issued | 1.83B | 16.99B | 10.57B | 375.00M | 5.12B |
| Total Debt Repaid | -306.00M | -435.00M | -300.00M | -266.00M | 697.00M |
| Issuance of Common Stock | 25.00M | 138.00M | 19.00M | 31.00M | 9.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.00 | -79.53M | -- | 0.00 | 0.00 |
| Other Financing Activities | -956.00M | 6.12B | -744.00M | -673.00M | -542.00M |
| Cash from Financing | 6.98M | 192.81M | 114.37M | -6.42M | 63.45M |
| Foreign Exchange rate Adjustments | -59.20K | -274.60K | 203.80K | -782.80K | 1.93M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 20.68M | 76.07M | -26.30M | -5.15M | -72.08M |
